Jeanette L. Tingstedt

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Differential recognition of influenza A virus H1N1 neuraminidase by DNA vaccine-induced antibodies in pigs and ferrets.

Differential recognition of influenza A virus H1N1 neuraminidase by DNA vaccine-induced antibodies in pigs and ferrets.

Journal: Frontiers in immunology

Published: April 05, 2023

Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2.

Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2.

Journal: NPJ vaccines

Published: June 12, 2021

Impact of Age and HIV Status on Immune Activation, Senescence and Apoptosis.

Impact of Age and HIV Status on Immune Activation, Senescence and Apoptosis.

Journal: Frontiers in immunology

Published: July 15, 2020

Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model.

Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model.

Journal: Vaccine

Published: June 09, 2020

Increased systemic inflammation and altered distribution of T-cell subsets in postmenopausal women.

Increased systemic inflammation and altered distribution of T-cell subsets in postmenopausal women.

Journal: PloS one

Published: July 28, 2019

The impact of concurrent HIV and type II diabetes on immune maturation, immune regulation and immune activation.

The impact of concurrent HIV and type II diabetes on immune maturation, immune regulation and immune activation.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: January 07, 2019

Cross-Reactive Antibodies With the Capacity to Mediate HIV-1 Envelope Glycoprotein-Targeted Antibody-Dependent Cellular Cytotoxicity Identified in HIV-2-Infected Individuals.

Cross-Reactive Antibodies With the Capacity to Mediate HIV-1 Envelope Glycoprotein-Targeted Antibody-Dependent Cellular Cytotoxicity Identified in HIV-2-Infected Individuals.

Journal: The Journal of infectious diseases

Published: September 25, 2018

HIV-Specific CD8+ T Cell-Mediated Viral Suppression Correlates With the Expression of CD57.

HIV-Specific CD8+ T Cell-Mediated Viral Suppression Correlates With the Expression of CD57.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: January 14, 2016

Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T Cells.

Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T Cells.

Journal: PloS one

Published: July 01, 2015

HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).

HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).

Journal: PloS one

Published: June 26, 2015

HIV-specific ADCC improves after antiretroviral therapy and correlates with normalization of the NK cell phenotype.

HIV-specific ADCC improves after antiretroviral therapy and correlates with normalization of the NK cell phenotype.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: November 14, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026